| Next 10 |
Ad
Motley Fool News Releases and Press Releases
Motley Fool news releases related news releases and press releases on the OTC NASDAQ and NYSE markets.
-
STAAR Surgical (NASDAQ: STAA) stock was up by 16% as of 3:36 p.m. ET on Thursday after it smashed the market's expectations for its second-quarter earnings, reporting net sales of $81.1 million and $0.26 in net income per diluted share. That works out to be 30% growth in its total r...
-
The crypto winter wasn't particularly frosty on Thursday afternoon, with the prices of top coins and tokens rising at least marginally. You wouldn't know that from the performance of one of the top cryptocurrency exchange operators, however. Coinbase Global (NASDAQ: COIN) was down b...
-
Shares of online eyewear retailer Warby Parker (NYSE: WRBY) are soaring in the wake of the company's second-quarter earnings report. The stock jumped as much as 30% this morning, settling down to a 20% gain as of 2 p.m. ET. Warby Parker's adjusted bottom line showed a net loss o...
-
There was a great deal of life in Wave Life Sciences (NASDAQ: WVE) stock on Thursday. As of midafternoon trading, investors had bid the company's share price up by more than 25%, comparing very favorably to the marginal gain eked out by the S&P 500 index. That was due almost...
-
Shares of oil and gas explorer Devon Energy (NYSE: DVN) , LNG terminal company Tellurian (NYSEMKT: TELL) , and energy services company Core Laboratories (NYSE: CLB) were rallying today, up 7.3%, 6%, and 5.5%, respectively, as of 1:45 p.m. ET on Thursday. Each of ...
-
Shares of oil and gas explorer Devon Energy (NYSE: DVN) , LNG terminal company Tellurian (NYSEMKT: TELL) , and energy services company Core Laboratories (NYSE: CLB) were rallying today, up 7.3%, 6%, and 5.5%, respectively, as of 1:45 p.m. ET on Thursday. Each of ...
-
Shares of oil and gas explorer Devon Energy (NYSE: DVN) , LNG terminal company Tellurian (NYSEMKT: TELL) , and energy services company Core Laboratories (NYSE: CLB) were rallying today, up 7.3%, 6%, and 5.5%, respectively, as of 1:45 p.m. ET on Thursday. Each of ...
-
Shares of Sonos (NASDAQ: SONO) cratered this morning after the popular speaker maker reported a big sales miss last night (but an earnings beat) -- and a key executive's resignation. Analysts had predicted Sonos would report $0.07 per share in pro forma profits for its fiscal th...
-
While it's a relatively quiet day for the Nasdaq Composite (NASDAQINDEX: ^IXIC) itself today, there's a lot of volatility within its component stocks. As of 1:23 p.m. ET on Aug. 11, the stock index is up a modest 0.25%. That's good enough to keep it up more than 20% from the rec...
-
While it's a relatively quiet day for the Nasdaq Composite (NASDAQINDEX: ^IXIC) itself today, there's a lot of volatility within its component stocks. As of 1:23 p.m. ET on Aug. 11, the stock index is up a modest 0.25%. That's good enough to keep it up more than 20% from the rec...
Now Trending
Trending Stock
109.87%Change Percent:
ChemoCentryx Inc. Company Name:
CCXI Stock Symbol:
NASDAQ Market:
chemocentryx.com Website:
MENU
CCXI Stock
CCXI Quote
CCXI Short
CCXI News
CCXI Articles
Get CCXI Stock Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
RECENT CCXI NEWS
-
SAN CARLOS, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the cancellation of its second quarter 2022 financial results conference call scheduled for Tuesday, August 9, 2022, at 5:00 p.m. ET. The call is being cancelled due to the August 4, 20...
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips <img width="1600" height="900" class="aligncenter size-full wp-image-1630608" src="https://investorplace.com/wp-content/uploads/2020/06/nkla-stock-1600.png" alt="Nikola ( NKLA ) badge on the front of a matte black car...
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock ChemoCentryx (NASDAQ: CCXI ) stock is rocketing higher on Thursday as investors react to news of an acquisition deal with Amgen (NASDAQ: AMGN ). This deal has Amgen agreeing to acq...